Expression of Fos-related antigens in the nucleus accumbens during opiate withdrawal and their attenuation by a D2 dopamine receptor agonist

被引:24
作者
Walters, CL [1 ]
Aston-Jones, G [1 ]
Druhan, JP [1 ]
机构
[1] Univ Penn, Med Ctr, Ctr Neurobiol & Behav, Dept Psychiat, Philadelphia, PA 19104 USA
关键词
nucleus accumbens; Fos-related antigens; dopamine receptors; opiate withdrawal; morphine; drug abuse;
D O I
10.1016/S0893-133X(00)00113-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Previous studies from this laboratory indicated that D2 dopamine (DA) receptors within the nucleus accumbens (NAc) are important for regulating somatic signs of opiate withdrawal. The present study measured the expression of Fos-related antigens (FRAs) within the NAc during opiate withdrawal to determine whether decreases in somatic withdrawal signs produced by a D2 receptor agonist are accompanied by related changes in accumbens neuronal activity. In an initial experiment, quantitative analyses of FRA immunoreactivity revealed increases in the number of FRA-positive cells throughout the NAc of opiate dependent animals undergoing naltrexone-precipitated withdrawal relative to dependent or non-dependent animals that did not experience withdrawal. A second experiment showed that somatic signs and FRA expression within the NAc could each be attenuated when the D2 agonist propylnorapomorphine (NPA; 0.1 or 0.3 mg/kg, i.p.) was administered prior to naltrexone-precipitated withdrawal. These findings suggest that D2 regulation or neuronal activity within the NAc may be important for the expression of opiate withdrawal symptoms. (C) 2000 American College of Neuropsychopharmacology. Published by Elsevier Science Inc. All rights reserved.
引用
收藏
页码:307 / 315
页数:9
相关论文
共 46 条
  • [1] PROFOUND DEPRESSION OF MESOLIMBIC DOPAMINE RELEASE AFTER MORPHINE-WITHDRAWAL IN DEPENDENT RATS
    ACQUAS, E
    CARBONI, E
    DICHIARA, G
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 193 (01) : 133 - 134
  • [2] Alheid GF, 1996, PROG BRAIN RES, V107, P461
  • [3] EFFECTS OF MORPHINE AND MORPHINE-WITHDRAWAL ON ADRENERGIC-NEURONS OF THE RAT ROSTRAL VENTROLATERAL MEDULLA
    BARABAN, SC
    STORNETTA, RL
    GUYENET, PG
    [J]. BRAIN RESEARCH, 1995, 676 (02) : 245 - 257
  • [4] Berridge CW, 1997, SYNAPSE, V27, P230, DOI 10.1002/(SICI)1098-2396(199711)27:3<230::AID-SYN8>3.0.CO
  • [5] 2-E
  • [6] IMMUNOHISTOCHEMICAL STUDIES OF NORADRENERGIC-INDUCED EXPRESSION OF C-FOS IN THE RAT CNS
    BING, GY
    STONE, EA
    ZHANG, Y
    FILER, D
    [J]. BRAIN RESEARCH, 1992, 592 (1-2) : 57 - 62
  • [7] BROWN EE, 1992, J NEUROSCI, V12, P4112
  • [8] Chieng B, 1998, J NEUROSCI, V18, P7033
  • [9] N-N-PROPYLNORAPOMORPHINE-H-3 - NOVEL AGONIST LIGAND FOR CENTRAL DOPAMINE RECEPTORS
    CREESE, I
    PADGETT, L
    FAZZINI, E
    LOPEZ, F
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1979, 56 (04) : 411 - 412
  • [10] WITHDRAWAL FROM MORPHINE OR AMPHETAMINE - DIFFERENT EFFECTS ON DOPAMINE IN THE VENTRAL-MEDIAL STRIATUM STUDIED WITH MICRODIALYSIS
    CRIPPENS, D
    ROBINSON, TE
    [J]. BRAIN RESEARCH, 1994, 650 (01) : 56 - 62